Bacterial Expression, NMR, and Electrophysiology Analysis of Chimeric Short/Long-chain α-Neurotoxins Acting on Neuronal Nicotinic Receptors

Abstract Different snake venom neurotoxins block distinct subtypes of nicotinic acetylcholine receptors (nAChR). Short-chain α-neurotoxins preferentially inhibit muscle-type nAChRs, whereas long-chain α-neurotoxins block both muscle-type and α7 homooligomeric neuronal nAChRs. An additional disulfide in the central loop of α- and κ-neurotoxins is essential for their action on the α7 and α3β2 nAChRs, respectively. Design of novel toxins may help to better understand their subtype specificity. To address this problem, two chimeric toxins were produced by bacterial expression, a short-chain neurotoxin II Naja oxiana with the grafted disulfide-containing loop from long-chain neurotoxin I from N. oxiana, while a second chimera contained an additional A29K mutation, the most pronounced difference in the central loop tip between long-chain α-neurotoxins and κ-neurotoxins. The correct folding and structural stability for both chimeras were shown by 1H and 1H-15N NMR spectroscopy. Electrophysiology experiments on the nAChRs expressed in Xenopus oocytes revealed that the first chimera and neurotoxin I blockα7 nAChRs with similar potency (IC50 6.1 and 34 nm, respectively). Therefore, the disulfide-confined loop endows neurotoxin II with full activity of long-chain α-neurotoxin and the C-terminal tail in neurotoxin I is not essential for binding. The A29K mutation of the chimera considerably diminished the affinity for α7 nAChR (IC50 126 nm) but did not convey activity at α3β2 nAChRs. Docking of both chimeras toα7 andα3β2 nAChRs was possible, but complexes with the latter were not stable at molecular dynamics simulations. Apparently, some other residues and dimeric organization of κ-neurotoxins underlie their selectivity for α3β2 nAChRs.